Immunovant, Inc.
Immunovant, Inc. (IMVT) Stock Forecast & Analyst Price Target
Wall Street consensus, 12-month price targets, model projections, and EPS/revenue estimates — from analyst data and price history.
imvt · stock forecast · 23 analysts (3M) · FMP · updated Jun 8, 2026
Analyst Rating & Consensus
Based on 23 Wall Street analysts in the past 3 months
Buy
23 analysts
consensus
Rating Breakdown
12-Month Price Target
High
$50.00
Consensus
$43.67
+41.4% upside
Low
$40.00
Median: $41 · Last Close: $30.88
12-Month Price Target Forecast
Historical closing prices + analyst 12-month price target forecast cone
Consensus Target
$43.67
41.4% upside
High Target
$50
61.9%
Low Target
$40
29.5%
Current Price
$30.88
as of today
Based on analyst price targets, the IMVT stock price prediction for the next 12 months ranges from $40 to $50. The consensus IMVT price forecast of $43.67 implies 41.4% upside from the current price of $30.88.
Short-Term Price Prediction
BullAlgorithmically generated · Updated daily
| Date | Predicted Price | Change |
|---|---|---|
| 2026-06-09 | $30.99 | ↑ 0.35% |
1-day model range: $30.58–$31.4. Peak: $31.4 (+0.35%).
Long-Term Stock Price Prediction
Annual stock price forecast · 2027 / 2028 / 2029 / 2030 / 2031
| Year | Avg Price | Change |
|---|---|---|
| 2027 | $21 | -30.8% |
| 2028 | $17 | -43.5% |
| 2029 | $16 | -49.8% |
| 2030 | $14 | -53.1% |
| 2031 | — | -55.0% |
Stock Forecast Based on Technical Analysis
14 TA signals (SMA×6 + EMA×6 + RSI + MACD) · EEAT method transparency
Market Sentiment
NEUTRAL
Based on 14 technical indicators
Refreshes daily from EOD close
Moving Averages · IMVT · Jun 8, 2026
Latest Analyst Ratings & Upgrades
| Date | Brokerage | Action | Rating |
|---|---|---|---|
| 2026-05-26 | Guggenheim | Maintains | Buy→Buy |
| 2026-05-22 | Truist Securities | Maintains | Hold→Hold |
| 2026-05-21 | HC Wainwright & Co. | Maintains | Buy→Buy |
| 2026-05-21 | B of A Securities | Maintains | Buy→Buy |
| 2026-04-15 | Goldman Sachs | Maintains | Neutral→Neutral |
| 2026-02-10 | HC Wainwright & Co. | Maintains | Buy→Buy |
| 2026-02-09 | Guggenheim | Maintains | Buy→Buy |
| 2026-01-08 | Truist Securities | Maintains | Hold→Hold |
| 2026-01-06 | Wolfe Research | Upgrade ↑ | Peer Perform→Outperform |
| 2025-12-15 | Goldman Sachs | Maintains | Neutral→Neutral |
Wall Street analysts have recently issued updated ratings on Immunovant, Inc. (IMVT) stock. Of the recent 112 rating actions, 5 were upgrades and 6 were downgrades. 23 analysts currently cover IMVT.
Analyst Recommendation Trends
IMVT analyst recommendation trends show increasing buy-side sentiment over the past 6 months. Buy rating actions changed from 2 to 3 per month.
Financial Forecast: EPS & Revenue Estimates
Revenue This Year
$7M
↓ 98.5% YoY
Revenue Next Year
$85M
↑ 1183.6% YoY
EPS This Year
$-2.62
EPS Next Year
$-2.54
↓ 3.1% YoY
EPS ForecastReported vs Estimated
Analysts forecast IMVT EPS of $-2.62 for the current fiscal year, based on estimates from 9 analysts. The IMVT revenue forecast is $7M for the current year. These are analyst consensus estimates via FMP / S&P Global.
About Forecast & Price Prediction
The IMVT stock forecast is supported by two independent data sources: analyst consensus ratings from 23 Wall Street analysts (S&P Global / FMP), and technical analysis calculated from historical EOD price data. The consensus IMVT price target is $43.67 (+41.4% upside), with an analyst consensus of Buy.
The IMVT short-term stock prediction for tomorrow is $30.99 (+0.35%). The IMVT stock price prediction for 2027 estimates an average of $21. The IMVT stock prediction for 2030 projects a range of $12–$17.
Immunovant, Inc. trades on NASDAQ under the ticker IMVT. The IMVT stock outlook for 2027 is broadly positive, supported by a Buy consensus among 78% of covering analysts.
Frequently asked questions
IMVT forecast · 8 questionsAccording to 23 Wall Street analysts, the average 12-month IMVT price target is $43.67, with a high forecast of $50.00 and a low of $40.00. The median price target is shown in the chart above when available. This implies +41.4% potential upside from the current price of $30.88.
· Analyst data: Financial Modeling Prep (FMP) · S&P Global Market Intelligence · Technical analysis: FMP /historical-price-eod/light · Updated: Hourly (analyst) · Daily (technical)
⚠ This information is provided for informational purposes only and does not constitute investment advice. Short-term and long-term price predictions are algorithmically generated and carry significant uncertainty. Past performance does not guarantee future results. Always conduct your own due diligence before making investment decisions.